Background Reported rates of Chlamydia trachomatis are on the rise contradicting the declining rates of C.trachomatis associated reproductive sequelae in Western countries. Population based evaluation of the real trend of C. trachomatis infection is important to contemplate prevention efforts. We studied C. trachomatis occurrence during the past 20 years in Finland comparing incidence rate data...

Chlamydia trachomatis was isolated from 26% of urethral swabs taken from 509 men with urethritis. The highest yield of 68% was obtained from a selected group of men with nonspecific urethritis (NSU) who had a frank urethral discharge. This is a higher than in previous reports, and is significantly higher than the isolation of C. trachomatis from men with less severe urethritis. The higher yield...

The in vitro activities of nemonoxacin, levofloxacin, azithromycin, and doxycycline were tested against 10 isolates each of Chlamydia trachomatis and Chlamydia pneumoniae. The MICs at which 90% of the isolates of both C. trachomatis and C. pneumoniae were inhibited (MIC90s) were 0.06 μg/ml (range, 0.03 to 0.13 μg/ml). The minimal bactericidal concentrations at which 90% of the isolates were kil...

The accuracy of the Surecell Chlamydia Test Kit (Kodak Clinical Products, Rochester, N.Y.) in detecting neonatal conjunctival infection caused by Chlamydia trachomatis was determined by comparison of this enzyme immunoassay with the isolation of C. trachomatis in tissue culture. Kodak Surecell is a rapid monoclonal antibody-based membrane capture enzyme immunoassay which can be processed in the...

Chlamydia are Gram negative obligate intracellular bacteria of eukaryotic cells and have a unique developmental cycle consisting of formation of infectious particle called elementary body and non-infectious particle called reticulate body. They are included in the order Chlamydiales and the order Chlamydiales belongs to the class Chlamydiae, phylum Chlamydiae, domain bacteria. The genus Chlamyd...

BACKGROUND Poor awareness and knowledge of Chlamydia trachomatis could be a barrier to uptake of screening. This study aimed to determine the level of awareness and knowledge of chlamydia among young people who were being approached in a variety of community settings and offered opportunistic screening. METHODS Men and women aged 16-24 years were approached in education, health and fitness, a...

Evaluation of Copan FLOQSwab for the molecular detection of Chlamydia trachomatis by Abbott RealTime CT PCR Liselotte Coorevits, Canelle Vanscheeuwijck, Ans Traen*, Luk Bingé, Inge Ryckaert, Elizaveta Padalko Department of Laboratory Medicine, Ghent University Hospital, Belgium, Pasop VZW, Belgium, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Belgium, School ...

We detected Chlamydia trachomatis biovar L2 in vaginal swab specimens of 7 women with vaginal discharge in South Africa. Whole-genome sequencing directly from clinical specimens identified a closely related cluster of strains. The clinical role of this infection in the context of syndromic management should be clarified.